Enliven Therapeutics
ELVN
ELVN
38 hedge funds and large institutions have $61.8M invested in Enliven Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.
Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
11
Reduced
8
Closed
10
Calls
–
Puts
$60K
Net Calls
-$60K
Net Calls Change
-$60K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$17.9M |
2 |
LPC
2
Lion Point Capital
New York
|
$3.4M |
3 |
RSCM
3
Rock Springs Capital Management
Baltimore,
Maryland
|
$3.38M |
4 |
LCM
4
Laurion Capital Management
New York
|
$1.22M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.98M |